Objective: To investigate the relationship between chemical structure and physiological effect, the efficacy and the molecular mechanisms involved in the reduction of body weight by C18 fatty acids (stearic, elaidic, oleic, linoleic and 2-hydroxyoleic acids (2-OHOA)). Design: Ad libitum fed, lean Wistar Kyoto rats treated orally with up to 600 mg kg À1 of the fatty acids or vehicle every 12 h for 7 days. Besides, starved rats and rats pairfed to the 2-OHOA-treated group served as additional controls under restricted feeding conditions. Measurements: Body weight, food intake, weight of various fat depots, plasma leptin, hypothalamic neuropeptides, uncoupling proteins (UCP) in white (WAT) and brown adipose tissue (BAT) and phosphorylation level of cyclic AMP (cAMP) response element-binding protein (CREB) in WAT. Results: Only treatment with oleic acid and 2-OHOA induced body weight loss (3.3 and 11.4%, respectively) through reduction of adipose fat mass. Food intake in these rats was lower, although hypothalamic neuropeptide and plasma leptin levels indicated a rise in orexigenic status. Rats pairfed to the 2-hydroxyoleic group only lost 6.3% body weight. UCP1 expression and phosphorylation of CREB was drastically increased in WAT, but not BAT of 2-OHOA-treated rats, whereas no UCP1 expression could be detected in WAT of rats treated with oleic acid. Conclusion: Both cis-configured monounsaturated C18 fatty acids (oleic acid and 2-OHOA) reduce body weight, but the introduction of a hydroxyl group in position 2 drastically increases loss of adipose tissue mass. The novel molecular mechanism unique to 2-hydroxyoleic, but not oleic acid, implies induction of UCP1 expression in WAT by the cAMP/PKA pathwaydependent transcription factor CREB, most probably as part of a transdifferentiation process accompanied by enhanced energy expenditure.
Introduction
Body weight of mammals is regulated by numerous factors to preserve a tight energy balance. A well-characterized system for the regulation of long-term energy homeostasis via food intake is the adipose tissue-hypothalamus axis, which is controlled by the appetite-suppressing hormone, leptin. 1 The production of this adipocyte-derived cytokine augments with increasing quantities of stored triglycerides and correlates with plasma leptin levels. From plasma, leptin enters the brain via a saturable transport mechanism 2 and acts directly on the neurons of hypothalamic arcuate nucleus via leptin receptors expressed on these cells. These neurons coexpress neuropeptide Y (NPY) and agouti-related protein, which induce orexigenic (appetite-stimulating) and anabolic effects being suppressed by leptin, or proopiomelanocortin and cocaine-amphetaminerelated transcript, which are, in contrast, induced by leptin and stimulate anorexigenic (appetite-inhibiting) and catabolic actions, thereby promoting weight loss. Besides the control of food intake, another important control system of energy homeostasis is the extent of energy expenditure. Thermogenesis in rodents primarily takes place in brown adipose tissue (BAT) by uncoupling of the mitochondrial respiratory chain. The pivotal protein in this event is the transmembrane uncoupling protein 1 (UCP1) of the mitochondrial inner membrane, which produces a proton leak between the matrix and the intermembrane space. In this way, the energy of the electrochemical gradient is dissipated as heat instead of producing ATP. 3 Usually, its physiological role limits the expression of UCP1 in rodents to BAT, whereas the uncoupling protein 2 (UCP2) is ubiquitously expressed and has different functions, such as the scavenging of reactive oxygen species and the transport of fatty acid anions out of the matrix. The uncoupling protein 3 (UCP3) is a muscle-specific isoform, which seems to be involved in fat oxidation and regulation of body fat content. 4 It has been demonstrated that fatty acids either in their unesterified form or as part of dietary fats are able to influence a variety of parameters related with energy homeostasis, such as body fat mass, lipid metabolism, thermogenesis, and food intake. For example, consumption of fish oil, whose major lipid components are the polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acid with a chain length of 20 and 22 carbon atoms, respectively, decreased total body fat in Wistar rats. 5 Nevertheless, also fatty acids with a chain length of 18 carbon atoms have the capacity to change body composition. It has been demonstrated that conjugated linoleic acid, in particular the isomer with D10-trans-D12-cis configuration, 6 is able to reduce body fat mass by various mechanisms, that is, reduction of food intake, increase in energy expenditure and augmented apoptosis of adipocytes in white adipose tissue (WAT). 7 Chemical modification of naturally occurring fatty acids could be a way to improve their capacity to diminish excess body fat content. In this context, Berge and coworkers 8 introduced a sulfur atom in the saturated 16-carbon chain of palmitic acid, creating the synthetic tetradecylthioacetic acid. The modification avoids rapid metabolization of this fatty acid and is responsible for its antiobese and antidiabetic effect. Moreover, it has been recently shown that tetradecylthioacetic acid can also prevent the development of hypertension in a 2-kidney, 1-clip rat model. 9 Another attempt to potentiate the effects of natural fatty acids was the chemical introduction of a methyl group in position 2 of various types of conjugated linoleic acid, augmenting the capacity of some of them to activate nuclear peroxisome proliferator-activated receptors. 10 Indeed, such an activation should increase lipid metabolism, although this has not yet been proven for these modified fatty acids in an animal model. In this context, our group has designed a synthetic derivative of oleic acid with a hydroxyl group in the a-position, 2-hydroxy-D9-cis-octadecenoic acid or briefly 2-OHOA. Besides its capacity to lower blood pressure very efficiently in spontaneously hypertensive rats, 11 the compound also markedly reduced body weight in treated animals. This study attempts to elucidate the general relationship between the chemical structure and the capacity to lower body weight of closely related C18 fatty acids in conjunction with the implicated molecular mechanisms. It comprises naturally occurring fatty acids, which are either saturated (stearic acid) and D9-cis-and D9-trans-monounsaturated (oleic and elaidic acids, respectively) or D9-cis-D12-cis-polyunsaturated (linoleic acid) as well as a D9-cis-monounsatured synthetic fatty acid (2-OHOA). ). Sixteen-week-old male Wistar Kyoto rats with an average weight of approximately 300 g were randomly assigned to the corresponding treatment groups and housed in individual cages some days before basal values were recorded. The different treatment groups received up to 600 mg kg À1 every 12 h of the following compounds: (1) vehicle; (2) oleic acid; (3) 2-OHOA; (4) elaidic acid; (5) stearic acid; (6) linoleic acid. Another group was starved during the 7 days to determine the maximum body and adipose tissue weight loss, which could be achieved by 100% food restriction, as well as the corresponding leptin and food-intake-regulating neuropeptide levels. Furthermore, an additional group of rats was pairfed to the 2-OHOA group to study whether the reduced food intake in this group could be the exclusive cause for the detected loss of body weight and how food-intake-regulating neuropeptide levels are altered by a food restriction of this extent. All rats had ad libitum access to food and water during the experiment with the exception of pairfed and starved animals, which were food restricted. Body weight, food 
Materials and methods
Real-time PCR quantification was performed using the LightCycler System (Roche Diagnostics) including a melting curve analysis of the final products. Expression results were normalized according to the housekeeping gene expression (18S ribosomal RNA).
Immunoblot analysis and quantification of specific immunoreactivity Quantitative immunoblotting was performed as described earlier. 12 Briefly, proteins were run on an SDS-polyacrylamide gel and transferred to nitrocellulose membranes. These membranes were blocked and incubated with the specific primary antibodies: polyclonal anti-phosphoCREB (diluted 1:2000), anti-UCP1 (diluted 1:1000), monoclonal anti-CREB (1:1000) and anti-actin (diluted 1:3000). The primary antibodies were detected with horseradish peroxidase-linked secondary antibodies and visualized with the ECL western blot detection system followed by exposure to ECL hyperfilm. Quantification was performed by image analysis of the immunoreactive bands on the film and normalized against a standard curve, which was loaded on the same gel.
Data analysis
Data are mean ± s.e.m. from the number of animals indicated (n). The statistical significance was calculated using GraphPad Software. One-way analysis of variance (ANOVA) followed by Bonferroni's test was used for statistical evaluations. Differences were considered statistically significant at Po0.05.
Results
Effect of oral administration of C18 fatty acids on rat body weight Oral administration of the studied fatty acids was elected, because it is a natural way of application and therefore less prone to provoke artifacts caused by unphysiological experimental conditions. Oleic acid (600 mg kg À1 every 12 h) induced a slight reduction of rat body weight, which started to be statistically significant at the fifth day of treatment, with a decline of À3.0±0.58% and a final reduction of À3.3 ± 0.55% after 1-week treatment with respect to vehicle-treated control group (Figure 1a ). In contrast, at the same dose, the effect of 2-OHOA on body weight was already statistically significant after the second day of treatment (À2.8 ± 0.79%) and reached its maximum after 7 days (À11.4±1.00%). The difference in efficacy between oleic acid and 2-OHOA started to be significant at the fourth day of treatment. Starved rats did not receive any food during the treatment to determine the maximum body weight loss that could be achieved by food restriction (À17.8 ± 0.86%). In contrast, oral administration of stearic, elaidic and linoleic acid (600 mg kg À1 every 12 h) did not lower body weight (Figure 1b) . Moreover, the effect of oleic acid and 2-OHOA on body weight was dose-dependent in the case of 2-OHOA and statistically significant from a dose of 300 mg kg À1 every 12 h (Figure 1c ).
Effect of oral administration of oleic acid and 2-OHOA on rat adipose tissue mass and plasma leptin levels To study whether the observed loss of body weight was accompanied by a reduction of adipose tissue mass, distinct adipose tissues of rats with a statistically significant decline of body weight were dissected. The reduction of total dissected adipose tissue mass from rats treated for 7 days with oleic acid or 2-OHOA (600 mg kg À1 every 12 h) or starved rats was 15.8 ± 2.4, 35.8 ± 4.9 or 50.3 ± 3.0%, respectively, compared to vehicle-treated rats (Figure 2a) . However, the reduction of adipose tissue mass differed considerably with respect to the type of adipose tissue and was especially tissue-dependent in the case of oleic acid. For example, ) and showed lower values in treatments with oleic acid, 2-OHOA or in starved rats (2.29 ± 0.25, 1.62 ± 0.17 or 0.36 ± 0.04 ng ml Effect of oral administration of C18 fatty acids on ad libitum food intake During oral treatment with C18 fatty acids (600 mg kg À1 every 12 h), only oleic acid-and 2-OHOA-treated rats showed a reduction of accumulated food intake compared to the control group (19.1±2.9 and 36.1±2.7%, respectively) ( Figure 3a) . To demonstrate whether the reduction of food intake, which was observed in the 2-OHOA-treated group, was the only cause of the detected loss of body weight, a group of rats was food-restricted to the exact extent that was consumed by the 2-OHOA-treated rats (pairfed). Indeed, pairfed rats also showed a reduction of body weight, which was significant from the first day of treatment (Figure 3b) . However, this reduction of body weight was not equal to that Effect of C18 fatty acids on body weight O Vögler et al of 2-OHOA-treated rats and started to be significantly different at the fifth day of pairfeeding. At the end of the experiment, pairfed rats lost only 6.3 ± 0.5% weight compared to 11.4 ± 1.0% of 2-OHOA-treated ones.
Effect of oleic acid and 2-OHOA on appetite-regulating hypothalamic neuropeptides
To evaluate whether the observed reduction of food intake was correlated with hypothalamic regulation of food intake, a potential downregulation of appetite-stimulating or upregulation of satiety-inducing hypothalamic neuropeptides was examined by quantitative real-time PCR. Transcription of NPY was enhanced in both the oleic acid and 2-OHOA group (1.5±0.1 and 2.2±0.3 AU, respectively), but only significantly in the latter (Figure 4) . Moreover, rats pairfed to the 2-OHOA group showed a very similar increase in NPY compared to these rats (2.0±0.3 AU), which was also significant. Agouti-related protein slightly augmented in these two groups and pairfed rats but increased drastically in starved rats (2.8±0.3 AU), indicating that stimulation of appetite seems to be regulated differently in starved and fatty acid-treated rats. Proopiomelanocortin mRNA levels remained nearly unchanged in all five groups, and only a minor, insignificant rise of cocaine-amphetamine related transcript could be detected in oleic acid-treated rats (1.5±0.3 AU).
Effect of oleic acid and 2-OHOA on transcription of UCPs in BAT and WAT
The possibility that the reduction of adipose tissue mass induced by oleic acid and 2-OHOA was caused by an Effect of C18 fatty acids on body weight O Vögler et al effect on proteins involved in thermogenic energy expenditure in these tissues was tested by quantitative real-time PCR determination of the levels of UCPs in interscapular BAT and retroperitoneal WAT of vehicle-, oleic acid-and 2-OHOA-treated rats. In BAT, only statistically insignificant differences in mRNA transcription between treated and control rats could be detected for all UCP isoforms ( Figure 5) . Still, the largest increases were observed for UCP1 and UCP3 transcription levels in rats treated with 2-OHOA (1.6±0.6 and 1.8±0.4 AU). In contrast, UCP1 transcription was enormously enhanced in WAT of these rats (28.2± 13.9 AU). This increase was accompanied by a rise in transcription of UCP3 mRNA in the 2-OHOA (3.5±0.5 AU) but not in the oleic acid group (0.9±0.1 AU). These results suggest the possibility of a transdifferentiation process of WAT into a tissue with similarities to BAT. To test this option, the mRNA levels of COX8H, a protein that forms part of complex IV of the respiratory chain and is considered as a mitochondrial marker, were determined. Indeed, the transcription levels of this protein were also strongly increased in rats treated with 2-OHOA but markedly reduced in the oleic acid group (24.3 ± 13.5 and 0.5 ± 0.2 AU, respectively).
Effect of oleic acid and 2-OHOA on CREB-phosphorylation and UCP1 expression in WAT In agreement with previously published results and the physiological role of WAT, which is the storage of energy and not its dissipation, no UCP1 protein expression was detectable in retroperitoneal WAT of control rats by immunoblotting. This was also true for rats treated with oleic acid. In sharp contrast, UCP1 protein expression was easily detectable in 2-OHOA-treated rats, confirming that the observed rise in transcription of RNA in fact led to protein expression in this tissue (Figure 6a ). Moreover, the phosphorylation level of the UCP1 transcription factor CREB was increased about fourfold in WAT of 2-OHOA-treated rats compared to control. In contrast, CREB phosphorylation was not detectable in rats treated with oleic acid, although the total amount of CREB expression augmented 48.8 ± 18.0% (Figure 6b ).
Discussion
Oral administration of chemically closely related C18 fatty acids showed different effects on body weight, adipose tissue Figure 4 Effect of oral administration of oleic acid and 2-OHOA on appetite-regulating hypothalamic neuropeptides. Levels of hypothalamic NPY, agouti-related protein, proopiomelanocortin and cocaine-amphetamine-related transcript were determined by quantitative real-time PCR after 7 days of oral administration of oleic acid or 2-OHOA (600 mg kg À1 every 12 h) or vehicle. Pairfed rats received the same daily amount of food as the 2-OHOA group, and starved rats did not receive any food but water ad libitum. Each column represents mean ± s.e.m. of six rats with the exception of starved rats (n ¼ 5). *Po0.05 and **Po0.01 versus control set at 1.0 (one-way ANOVA followed by Bonferroni's test).
Effect of C18 fatty acids on body weight O Vögler et al mass and food intake, depending on their chemical structure.
Although both cis-monounsaturated fatty acids used in this study, oleic acid and 2-OHOA, were able to induce reductions in all of the above-mentioned parameters, insertion of an additional cis-double bond in position D12 (linoleic acid), as well as trans-isomerization (elaidic acid) or deletion (stearic acid) of the cis-configured D9 double bond, completely abolished these effects. Nevertheless, also oleic acid and 2-OHOA showed largely different efficacies in the reduction of body weight, because the simple introduction of a hydroxyl-group in the a-position of oleic acid potentiated its effect more than fourfold. A possible explanation for this increase would be the fact that a-hydroxy-substituted fatty acids cannot be straightforwardly metabolized via the b-oxidation pathway but must first be degraded by an enzyme pertaining to the a-oxidation pathway, that is, 2-hydroxyphytanoyl-CoA lyase. 14 The latter may become rapidly saturated, as it represents a secondary oxidation pathway for non-abundant natural fatty acids and, as a consequence, 2-OHOA may accumulate to a much higher degree in treated rats than oleic acid, which is predominantly used as a source of energy. This idea would also be in agreement with the observation that 2-OHOA started to be effective at lower doses than oleic acid, concerning the reduction of body weight. 
Effect of C18 fatty acids on body weight O Vögler et al
It has been shown that intracerebroventricular administration of oleic acid lowers food intake by altering the levels of hypothalamic neuropeptides. 15 In these experiments, a reduction of the orexigenic, appetite-stimulating NPY was observed, which is in contrast to our results that rather indicate a slight rise of NPY in the case of oleic acid and a statistically significant increase in the case of 2-OHOA. However, it is not clear whether oral administration of the doses used in our study can lead to comparable hypothalamic concentrations of oleic acid (or 2-OHOA) as direct intracerebroventricular administration. Regardless, the increase of NPY levels of oleic acid-and 2-OHOA-treated rats observed in our experiments is in accordance with the lowered adipose tissue mass and plasma leptin levels. Interestingly, rats pairfed to the 2-OHOA group revealed a very similar increase in NPY levels compared to their 2-OHOA-treated counterpart, indicating that the rise of NPY in both groups is most likely induced in an analogous way by the reduced amount of consumed food. Together, these data suggest that the adipose tissue-plasma leptinhypothalamus axis was functioning properly in oleic acidand 2-OHOA-treated rats and that the reduction of food intake must be provoked by another mechanism, which was able to compensate the increase of hypothalamic NPY. In this context, Cox et al. 16 have shown that jejunal infusion of oleic acid is able to reduce food intake, most probably by celiac vagal afferent stimulation through cholecystokinin. However, another possible explanation for the reduction of body weight, at least for 2-OHOA-treated rats, could be the induction of a direct lipolytic effect on adipose tissue by this compound. Subsequently, the high amounts of unesterified fatty acids liberated from fat depots would be converted for the most part in ketone bodies by hepatic ketogenesis. 20 In fact, it has been shown that ketone bodies can reduce food intake, 21 meaning that the inhibition of food intake by 2-OHOA would rather be a secondary effect and not the cause of the reduction in body weight. Accordingly, rats that were pairfed with respect to the 2-OHOA group lost only about half of the body weight compared to 2-OHOA-treated rats, equally indicating that inhibition of food intake alone cannot be exclusively responsible for the observed degree of body-weight reduction. In line with this idea, the most obvious alteration in WAT of 2-OHOA-treated rats was a nearly 30-fold increase of UCP1 transcription. UCP1 is usually only expressed in significant amounts in BAT and not in WAT, so that the appearance of this protein in WAT is considered as a sign of a transdifferentiation process, that is, the conversion of WAT in a tissue with cellular similarities to BAT. Acquirement of BAT-like features by WAT can be provoked by physiological conditions, such as cold stress, 22 or by pharmacological intervention, such as b 3 -adrenergic stimulation. 23 Moreover, UCP1 expression in WAT is related to body weight loss in obese and UCP1 transgenic mice 24, 25 and can also occur in human white adipocytes. 26 Stimulation of b 3 -adrenergic receptors increases intracellular cAMP, thereby activating protein kinase A (PKA), which then phosphorylates the UCP1 transcription factor CREB and hormone-sensitive lipase, resulting in UCP1 Effect of C18 fatty acids on body weight O Vögler et al expression and lipolysis of stored fat from adipocyte lipid droplets. 27, 28 Although one might speculate that these two physiological responses to b-adrenergic stimulation are independent of each other, a recent study has demonstrated that the b 3 -adrenergic agonist, CL-316,243, could reduce white-fat pad size and the size of adipocytes only in wildtype but not in UCP1 knockout mice. 29 A DNA microarray study of WAT from obese (fa/fa) Zucker rats treated with the b 3 -adrenoceptor agonist KTO-7924 revealed specifically enhanced mRNA expressions not only of UCP1 but also of COX8H, 30 which is the terminal enzyme of the mitochondrial respiratory chain 31 and likewise highly expressed in BAT. 32 In line with these data, COX8H expression was also drastically increased in 2-OHOA-treated rats. Even more important, also the phosphorylation level of the cAMPdependent UCP1 transcription factor CREB was significantly increased in these rats when compared to vehicle-treated ones. In this context, we have recently demonstrated that an enhancement of the cAMP/PKA pathway in vascular tissue is responsible for the reduction of blood pressure observed in spontaneously hypertensive and normotensive SpragueDawley rats after 2-OHOA treatment. 11, 33 In contrast, expression of COX8H and phosphorylation of CREB in rats treated with oleic acid declined to less than half of the levels of vehicle-treated control rats. This suggests that the high efficiency of 2-OHOA in the reduction of body weight is not caused by a simple potentiation of the activity of oleic acid but by a completely distinct mechanism. In summary, our data indicate that oral treatment with the cis-configured monounsaturated C18 fatty acids, oleic acid and 2-OHOA, have the capacity to reduce body weight when administered orally. 2-OHOA induces UCP1 expression in WAT by the cAMP/PKA pathway-dependent transcription factor CREB, resulting in a reduction of adipose fat mass probably accompanied by enhanced energy expenditure. Instead, oleic acid does not provoke these changes and must therefore act on a different molecular mechanism. In addition, these results demonstrate that minor changes in the chemical structure of a fatty acid can strongly influence its effectiveness, the activated molecular pathways and, as a consequence, its impact on body weight.
